Breaking News Instant updates and real-time market news.

FRTA

Forterra

$8.51

0.11 (1.31%)

18:12
11/04/19
11/04
18:12
11/04/19
18:12

Forterra reports Q3 EPS 35c, consensus 12c

Reports Q3 revenue $464.5M, consensus $439.01M. The company said, "Our Q3 results demonstrate continued progress in three key levers to advancing our business: improving plant level production efficiencies, strategic and tactical pricing discipline, and working capital optimization. While still in the early stages of delivering a full and fair return for the products we produce and the capital we deploy, we are glad to see our efforts begin to yield positive results to the bottom line."

  • 05

    Nov

FRTA Forterra
$8.51

0.11 (1.31%)

11/23/18
DBAB
11/23/18
NO CHANGE
Target $5
DBAB
Buy
Forterra price target lowered to $5 from $8 at Deutsche Bank
Deutsche Bank analyst Nishu Sood lowered his price target for Forterra to $5 saying sales growth in the company's Q3 suffered from shipment delays related to poor weather in major markets. However, backlogs were up in the quarter, reflective of the pent up work from project delays and according to management commentary, this should be margin accretive, adds the analyst. He keeps a Hold rating on Forterra shares.
01/23/19
EXAN
01/23/19
UPGRADE
EXAN
Outperform
Forterra upgraded to Outperform from Neutral at Exane BNP Paribas
08/07/19
GSCO
08/07/19
UPGRADE
GSCO
Buy
Forterra upgraded two notches to Buy from Sell at Goldman Sachs
Goldman Sachs analyst Jerry Revich double-upgraded Forterra to Buy from Sell
08/07/19
GSCO
08/07/19
UPGRADE
Target $8
GSCO
Buy
Forterra upgraded to Buy from Sell at Goldman Sachs
Goldman Sachs analyst Jerry Revich double upgraded Forterra to Buy from Sell and raised his price target for the shares to $8.00 from $4.25. The company's entire senior management team has turned over and pricing is now accelerating despite declining input costs, Revich tells investors in a research note. He believes the latter is likely to drive multiple expansion if it is sustained in the coming quarters. Revich continues to prefer Aggregates producers for construction cycle exposure, and he views Forterra as a "high risk/high reward option for investors."

TODAY'S FREE FLY STORIES

EVRI

Everi Holdings

$11.86

-1 (-7.78%)

16:43
12/05/19
12/05
16:43
12/05/19
16:43
Syndicate
Everi Holdings 10M share Secondary priced at $11.25 »

The deal priced below the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 06

    Dec

ZUMZ

Zumiez

$30.63

0.67 (2.24%)

16:39
12/05/19
12/05
16:39
12/05/19
16:39
Earnings
Zumiez raises FY19 SSS growth view to 4.0%-4.5% from prior view 2.0%-4.0% »

Based upon better than…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 05

    Dec

CRWD

Crowdstrike

$53.00

-2.04 (-3.71%)

16:38
12/05/19
12/05
16:38
12/05/19
16:38
Earnings
Crowdstrike raises FY20 EPS view to (53c)-(52c) from (65c)-(62c) »

Consensus (63c). Raises…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 12

    Dec

FNHC

Federated National

$15.37

-0.04 (-0.26%)

16:36
12/05/19
12/05
16:36
12/05/19
16:36
Hot Stocks
Federated National announces new $10M share repurchase program »

Federated National…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRWD

Crowdstrike

$53.00

-2.04 (-3.71%)

16:36
12/05/19
12/05
16:36
12/05/19
16:36
Earnings
Crowdstrike sees Q4 adjusted EPS (9c)-(8c), consensus (11c) »

Sees Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 12

    Dec

CRWD

Crowdstrike

$53.00

-2.04 (-3.71%)

16:35
12/05/19
12/05
16:35
12/05/19
16:35
Earnings
Crowdstrike reports Q3 adjusted EPS (7c), consensus (11c) »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 12

    Dec

EPZM

Epizyme

$15.32

-0.48 (-3.04%)

16:35
12/05/19
12/05
16:35
12/05/19
16:35
Upgrade
Epizyme rating change  »

Epizyme upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 18

    Dec

  • 23

    Jan

ESTA

Establishment Labs

$24.31

0.32 (1.33%)

16:35
12/05/19
12/05
16:35
12/05/19
16:35
Hot Stocks
Establishment Labs reaches one million Motiva implants milestone »

Establishment Labs…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IDT

IDT Corp

$7.47

0.26 (3.61%)

16:34
12/05/19
12/05
16:34
12/05/19
16:34
Earnings
IDT Corp reports Q1 EPS 10c vs. (2c) last year »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 12

    Dec

KODK

Kodak

$2.59

0.085 (3.39%)

16:33
12/05/19
12/05
16:33
12/05/19
16:33
Hot Stocks
Kodak's Karfunkel acquires over 4.4M common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PAC

GAP Airports

$99.66

-1.12 (-1.11%)

16:32
12/05/19
12/05
16:32
12/05/19
16:32
Hot Stocks
GAP Airports reports November traffic up 10.1% »

GAP Airports announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JOE

Saint Joe Co.

$19.49

0.7 (3.73%)

16:32
12/05/19
12/05
16:32
12/05/19
16:32
Hot Stocks
St. Joe, HomeCorp to build additional 120 apartment homes in Panama City Beach »

The St. Joe Company and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALEC

Alector

$19.44

-0.17 (-0.87%)

16:32
12/05/19
12/05
16:32
12/05/19
16:32
Hot Stocks
Alector announces FDA fast track designation granted to AL001 for dementia »

Alector announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MGLN

Magellan Health

$76.79

-0.12 (-0.16%)

16:31
12/05/19
12/05
16:31
12/05/19
16:31
Hot Stocks
Magellan Health names James Murray as President and COO »

Magellan Health announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SWIR

Sierra Wireless

$9.15

0.12 (1.33%)

16:31
12/05/19
12/05
16:31
12/05/19
16:31
Hot Stocks
Sierra Wireless CFO Dave McLennan retiring in mid-2020 »

Sierra Wireless CFO Dave…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Feb

ASR

Asur

$167.79

-1.88 (-1.11%)

16:30
12/05/19
12/05
16:30
12/05/19
16:30
Hot Stocks
Asur reports total November passenger traffic up 7.3% »

Asur announced that total…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AXNX

Axonics

$25.05

0.92 (3.81%)

16:30
12/05/19
12/05
16:30
12/05/19
16:30
Hot Stocks
Integrated Core Strategies reports 5.1% passive stake in Axonics »

Integrated Core…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

COO

Cooper Companies

$313.10

1 (0.32%)

16:30
12/05/19
12/05
16:30
12/05/19
16:30
Earnings
Cooper Companies sees Q1 EPS $2.65-$2.75, consensus $2.97 »

Sees Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 12

    Dec

  • 13

    Dec

16:30
12/05/19
12/05
16:30
12/05/19
16:30
Options
Preliminary option volume of 14.7M today »

Preliminary option volume…

COO

Cooper Companies

$312.96

0.86 (0.28%)

16:28
12/05/19
12/05
16:28
12/05/19
16:28
Earnings
Cooper Companies sees FY20 EPS $12.60-$13.30, consensus $13.10 »

Sees FY20 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 12

    Dec

  • 13

    Dec

BOLD

Audentes Therapeutics

$59.19

-0.09 (-0.15%)

, ALPMY

Astellas Pharma

$0.00

(0.00%)

16:27
12/05/19
12/05
16:27
12/05/19
16:27
Downgrade
Audentes Therapeutics, Astellas Pharma rating change  »

Audentes Therapeutics…

BOLD

Audentes Therapeutics

$59.19

-0.09 (-0.15%)

ALPMY

Astellas Pharma

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

ZUMZ

Zumiez

$30.63

0.67 (2.24%)

16:27
12/05/19
12/05
16:27
12/05/19
16:27
Earnings
Zumiez provides Q4 quarter to date sales update »

With the Thanksgiving…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 05

    Dec

ZUMZ

Zumiez

$30.63

0.67 (2.24%)

16:26
12/05/19
12/05
16:26
12/05/19
16:26
Earnings
Zumiez sees FY19 EPS $2.38- $2.46, consensus $2.16 »

Based upon better than…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 05

    Dec

COO

Cooper Companies

$312.96

0.86 (0.28%)

16:25
12/05/19
12/05
16:25
12/05/19
16:25
Earnings
Cooper Companies reports Q4 EPS $3.30, consensus $3.27 »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 12

    Dec

  • 13

    Dec

BIIB

Biogen

$299.30

9.95 (3.44%)

16:25
12/05/19
12/05
16:25
12/05/19
16:25
Conference/Events
Biogen to host conference call »

Biogen Chief Medical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 05

    Dec

  • 05

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.